GLG1 Activators
GLG1 Activators encompass a group of chemical compounds that indirectly augment the functional activity of GLG1 through various signaling pathways, primarily affecting glycosylation processes within cells. Forskolin and IBMX both increase intracellular cAMP levels, which can activate protein kinase A (PKA) and subsequently enhance the glycosylation pathways where GLG1 functions. PMA is a direct activator of protein kinase C (PKC), which is known to influence glycosylation signaling, potentially leading to the activation of GLG1. Sphingosine-1-phosphate operates through cell surface receptors to activate downstream signaling that may affect glycosylation, while Epigallocatechin gallate, through its modulation of various signal transduction pathways, could also influence the activity of GLG1 in the glycosylation process.
Furthermore, LY294002 and Wortmannin, as PI3K inhibitors, along with U0126, a MEK inhibitor, and SB203580, a p38 MAPK inhibitor, might alter key signaling pathways that indirectly support the glycosylation functions of GLG1. A23187 and Thapsigargin both increase intracellular calcium levels, which could activate calcium-dependent kinases enhancing GLG1-related glycosylation pathways. Genistein, with its tyrosine kinase inhibitory action, may further support the activity of GLG1 by reducing competition in phosphorylation events, thereby favoring glyGLG1 Activators.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin serves as an adenylate cyclase activator, increasing cAMP levels. Elevated cAMP enhances PKA activity, which can phosphorylate various proteins, potentially leading to the activation of GLG1 by promoting its functional role in glycosylation processes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, preventing the breakdown of cAMP. The resulting rise in cAMP levels could indirectly activate GLG1 by strengthening PKA-mediated glycosylation signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), which can influence pathways that modulate glycosylation, thereby potentially enhancing the activity of GLG1. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) engages S1P receptors, triggering downstream signaling that can influence glycosylation pathways, possibly leading to the enhanced functional activity of GLG1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is a catechin with antioxidant properties. It can modulate signal transduction pathways, potentially affecting the glycosylation process and thus the activity of GLG1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that could indirectly affect the glycosylation machinery by altering PI3K/AKT signaling, which may contribute to the activation of GLG1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAPK, which could shift cellular signaling in a way that promotes processes that enhance the functional role of GLG1 in glycosylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that elevates intracellular calcium levels, potentially activating calcium-dependent kinases that could positively influence the glycosylation pathways involving GLG1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that increases cytosolic calcium levels, possibly activating calcium-dependent signaling that enhances the functional activity of GLG1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that by reducing competitive phosphorylation reactions, may indirectly support the glycosylation functions where GLG1 is active. | ||||||